semaglutide in kidney disease can cause failure Results from this major trial show that reduced the risk of Semaglutide significantly reduces risk of

Time from randomization to first composite kidney event, first composite major cardio-vascular event, and first all-cause death event were analyzed using Cox proportional hazards model, with flozins at baseline used for stratification

It is important to remember that obesity is heterogenous, chronic and complex, says Vijaya Surampudi, MD, physician nutrition specialist and assistant director of the UCLA Weight Management Program (RFO)

At least a 50% reduction in eGFR from baseline

For patients reporting urinary side effects, the prescribing clinician can review symptoms, check for red flags, and recommend evaluation if needed